Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients

Pathogenesis of spondyloarthritis

(2012) Carmen Ambarus et al.   CURRENT OPINION IN RHEUMATOLOGY

Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical features

(2012) Raquel Celis et al.   ARTHRITIS RESEARCH & THERAPY

Antibodies to citrullinated  -enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis

(2011) B. A. Fisher et al.   ANNALS OF THE RHEUMATIC DISEASES

Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis

(2011) Troy Noordenbos et al.   ARTHRITIS AND RHEUMATISM

Preferential Association of Interferon Regulatory Factor 5 Gene Variants with Seronegative Rheumatoid Arthritis in 2 Swedish Case-Control Studies

(2011) CHUAN WANG et al.   JOURNAL OF RHEUMATOLOGY

Interleukin 15 Levels in Serum May Predict a Severe Disease Course in Patients with Early Arthritis

(2011) Isidoro González-Álvaro et al.   PLoS One

Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium

(2011) Jolien Suurmond et al.   ARTHRITIS RESEARCH & THERAPY

The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritis

(2010) D. van der Woude et al.   ANNALS OF THE RHEUMATIC DISEASES

Cutting Edge: Mast Cells Express IL-17A in Rheumatoid Arthritis Synovium

(2010) A. J. Hueber et al.   JOURNAL OF IMMUNOLOGY

Elevated Serum Interleukin 33 Is Associated with Autoantibody Production in Patients with Rheumatoid Arthritis

(2010) R. MU et al.   JOURNAL OF RHEUMATOLOGY

Anti-citrullinated peptide antibody-negative RA is a genetically distinct subset: a definitive study using only bone-erosive ACPA-negative rheumatoid arthritis

(2010) K. Ohmura et al.   RHEUMATOLOGY

Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis

(2009) L. Melis et al.   ANNALS OF THE RHEUMATIC DISEASES

Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis

(2009) Francisco Javier López-Longo et al.   ARTHRITIS AND RHEUMATISM

Alterations of the synovial T cell repertoire in anti-citrullinated protein antibody-positive rheumatoid arthritis

(2009) Tineke Cantaert et al.   ARTHRITIS AND RHEUMATISM

Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis

(2009) Rohit Aggarwal et al.   ARTHRITIS AND RHEUMATISM

Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis

(2009) Raimon Sanmartí et al.   ARTHRITIS RESEARCH & THERAPY

Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor   therapy in rheumatoid arthritis

(2008) J D Canete et al.   ANNALS OF THE RHEUMATIC DISEASES

Synovial lymphoid neogenesis does not define a specific clinical rheumatoid arthritis phenotype

(2008) Rogier M. Thurlings et al.   ARTHRITIS AND RHEUMATISM

Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis

(2008) V. Goeb et al.   RHEUMATOLOGY

Innate production of tumour necrosis factor   and interleukin 10 is associated with radiological progression of knee osteoarthritis

(2007) S Botha-Scheepers et al.   ANNALS OF THE RHEUMATIC DISEASES